Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The clinical implications of genetic risk for hypertension (HTN) and high low-density lipoprotein cholesterol (LDL-C) levels in incident chronic kidney disease (CKD) are unknown. This study aimed to examine whether polygenic risk scores (PRSs) for these two factors can predict the development of CKD.

Methods: We included 245,893 participants enrolled in UK Biobank during 2006-2010 and followed up until 2022. The primary exposures were the PRS for HTN (PRS HTN) and high LDL-C concentration (PRS LDL-C). The primary outcome was incident CKD, assessed using cause-specific competing-risk models.

Results: During a median follow-up of 13.7 years (interquartile range, 13.0-14.3 years), 7,771 individuals experienced CKD. A 1-standard deviation higher PRS HTN was associated with a 7% higher risk of incident CKD (hazard ratio [HR], 1.07; 95% confidence interval [CI], 1.05-1.10). However, PRS LDL-C showed no significant association with incident CKD. In a combined association analysis based on the four groups classified by the median values of PRS, the HRs were 1.03 (95% CI, 0.97-1.10) in the high LDL-C-risk group and 1.13 (95% CI, 1.06-1.20) in both the high HTN group and the combined high-risk group, compared with the reference group.

Conclusion: This study showed that individuals with a higher genetic predisposition to HTN were more likely to develop CKD than those predisposed to a high LDL-C concentration. Additionally, higher genetic predispositions for these two factors did not synergically contribute to the risk of CKD.

Download full-text PDF

Source
http://dx.doi.org/10.23876/j.krcp.24.255DOI Listing

Publication Analysis

Top Keywords

prs htn
12
incident ckd
12
polygenic risk
8
risk scores
8
low-density lipoprotein
8
lipoprotein cholesterol
8
incident chronic
8
chronic kidney
8
kidney disease
8
htn high
8

Similar Publications

Background: Cardiometabolic diseases (CMD) are a leading cause of morbidity and mortality. While both family history (FH) and polygenic risk scores (PRS) are predictive of CMD risk, few studies have systematically evaluated their independent and joint effects. This study aimed to quantify the individual contributions of FH and PRS, as well as their combined impact on CMD risk.

View Article and Find Full Text PDF

Background: The clinical implications of genetic risk for hypertension (HTN) and high low-density lipoprotein cholesterol (LDL-C) levels in incident chronic kidney disease (CKD) are unknown. This study aimed to examine whether polygenic risk scores (PRSs) for these two factors can predict the development of CKD.

Methods: We included 245,893 participants enrolled in UK Biobank during 2006-2010 and followed up until 2022.

View Article and Find Full Text PDF

Overweight-related hypertension (OrH), defined by the coexistence of excess body weight and hypertension (HTN), is an increasing health concern elevating cardiovascular disease risks. This study evaluated the prediction performance of polygenic risk scores (PRS) and methylation risk scores (MRS) for OrH in 7605 Chinese participants from two cohorts: the Chinese Academy of Sciences (CAS) and the National Survey of Physical Traits (NSPT). In CAS cohort, which predominantly consists of academics, males showed significantly higher prevalence of obesity, HTN, and OrH, along with worse metabolic syndrome indicators, compared to females.

View Article and Find Full Text PDF

Pulmonary renal syndrome (PRS) is a rare clinical syndrome characterized by pulmonary hemorrhage and rapidly progressing glomerulonephritis. It is commonly due to a rheumatologic etiology, including antineutrophil cytoplasm antibodies vasculitis or antiglomerular basement membrane disease. Given the rapid progression, patients are often empirically treated when there is high clinical suspicion for PRS.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated how well a polygenic risk score (PRS) for systolic blood pressure (SBP) can predict patients' responses to antihypertensive treatment and the risk of treatment-resistant hypertension.
  • The research focused on participants from the GenHAT study, specifically Black individuals who were assigned to treatment groups involving chlorthalidone or lisinopril.
  • The main outcomes measured were changes in blood pressure after six months and the likelihood of being classified as treatment-resistant hypertension based on defined criteria.
View Article and Find Full Text PDF